The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Fluorescence polarization assays in small molecule screening
Open accessAbstract
IMPORTANCE OF THE FIELD: Fluorescence polarization (FP) is a homogeneous method that allows rapid and quantitative analysis of diverse molecular interactions and enzyme activities. This technique has been widely utilized in clinical and biomedical settings, including the diagnosis of certain diseases and monitoring therapeutic drug levels in body fluids. Recent developments in the field have been symbolized by the facile adoption of FP in high-throughput screening and small molecule drug discovery of an increasing range of target classes. AREAS COVERED IN THIS REVIEW: The article provides a brief overview of the theoretical foundation of FP, followed by updates on recent advancements in its application for various drug target classes, including GPCRs, enzymes and protein-protein interactions. The strengths and weaknesses of this method, practical considerations in assay design, novel applications and future directions are also discussed. WHAT THE READER WILL GAIN: The reader is informed of the most recent advancements and future directions of FP application to small molecule screening. TAKE HOME MESSAGE: In addition to its continued utilization in high-throughput screening, FP has expanded into new disease and target areas and has been marked by increased use of labeled small molecule ligands for receptor-binding studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles of Fluorescence Spectroscopy
Lakowicz, J. R. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3061-6 · Cited by 26,947
Yung-Chi, C., & Prusoff, W. H. (1973) · Biochemical Pharmacology · doi:10.1016/0006-2952(73)90196-2 · Cited by 12,922
Anatomy of hot spots in protein interfaces
Bogan, A. A., & Thorn, K. S. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1843 · Cited by 1,988
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
Arkin, M. R., & Wells, J. A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1343 · Cited by 1,705 · cited 1×
“The debate over whether PPIs are druggable or not is largely due to the fact that they are characterized by large and ill-defined interfaces with variable contact points and a lack of deep and welldefined binding cavities [67].”
BackgroundAdenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“A2AAR is one of the four known subtypes of adenosine receptors (ARs), all of which are members of the GPCR superfamily [29].”
BackgroundBright Ideas for Chemical Biology
Lavis, L. D., & Raines, R. T. (2008) · ACS Chemical Biology · doi:10.1021/cb700248m · Cited by 1,290
From carbohydrate leads to glycomimetic drugs
Ernst, B., & Magnani, J. L. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2852 · Cited by 820
Polarisation de la lumière de fluorescence. Vie moyenne des molécules dans l'etat excité
Perrin, F. (1926) · Journal de physique · doi:10.1051/jphysrad:01926007012039000 · Cited by 630
Fluorescence Polarization/Anisotropy in Diagnostics and Imaging
Jameson, D. M., & Ross, J. A. (2010) · Chemical Reviews · doi:10.1021/cr900267p · Cited by 627
Nikolovska-Coleska, Z., Wang, R., Fang, X., Pan, H., Tomita, Y., Li, P., Roller, P. P., Krajewski, K., Saito, N. G., Stuckey, J. A., et al. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.055 · Cited by 548
Carbohydrates as future anti-adhesion drugs for infectious diseases
Sharon, N. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.008 · Cited by 512
Identification and Prediction of Promiscuous Aggregating Inhibitors among Known Drugs
Seidler, J., McGovern, S. L., Doman, T. N., & Shoichet, B. K. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030191r · Cited by 476
Protein methyltransferases as a target class for drug discovery
Copeland, R. A., Solomon, M. E., & Richon, V. M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2974 · Cited by 460
Refined structure of the Hirudin-thrombin complex
Rydel, T. J., Tulinsky, A., Bode, W., & Huber, R. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)80074-5 · Cited by 368
Cer, R. Z., Mudunuri, U., Stephens, R., & Lebeda, F. J. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp253 · Cited by 367
Fluorescence Polarization and Anisotropy in High Throughput Screening: Perspectives and Primer
Owicki, J. C. (2000) · SLAS Discovery · doi:10.1177/108705710000500501 · Cited by 303
Modulation of Protein–Protein Interactions with Small Organic Molecules
Berg, T. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200200558 · Cited by 292
Screening in a spirit haunted world
Shoichet, B. K. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.05.014 · Cited by 276
Sensitive assays for trypsin, elastase, and chymotrypsin using new fluorogenic substrates
Zimmerman, M. D., Ashe, B. M., Yurewicz, E. C., & Patel, G. F. (1977) · Analytical Biochemistry · doi:10.1016/0003-2697(77)90006-9 · Cited by 264
Fluorescence Spectroscopic Profiling of Compound Libraries
Simeonov, A., Jadhav, A., Thomas, C. J., Wang, Y., Huang, R., Southall, N. T., Shinn, P., Smith, J., Austin, C. P., Auld, D. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701301m · Cited by 262
Self-citationSmith, D. S., & Eremin, S. A. (2008) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-008-1897-z · Cited by 252
Liu, F., Chen, X., Allali-Hassani, A., Quinn, A. M., Wasney, G. A., Dong, A., Barsyte, D., Kozieradzki, I., Senisterra, G., Chau, I., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901543m · Cited by 239
Self-citationStructure-Based Drug Design and Optimization of Mannoside Bacterial FimH Antagonists
Han, Z., Pinkner, J. S., Ford, B., Obermann, R., Nolan, W., Wildman, S. A., Hobbs, D., Ellenberger, T., Cusumano, C. K., Hultgren, S. J., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100438s · Cited by 236
Inhibition of Polo-like Kinase 1 by Blocking Polo-Box Domain-Dependent Protein-Protein Interactions
Reindl, W., Yuan, J., Krämer, A., Strebhardt, K., & Berg, T. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.03.013 · Cited by 232
Antagonists of protein–protein interactions
Cochran, A. G. (2000) · Chemistry & Biology · doi:10.1016/s1074-5521(00)00106-x · Cited by 228
Fluorescence polarization analysis of protein-DNA and protein-protein interactions
Lundblad, J. R. (1996) · Molecular Endocrinology · doi:10.1210/me.10.6.607 · Cited by 226
Parker, G. J., Law, T. L., Lenoch, F. J., & Bolger, R. E. (2000) · SLAS Discovery · doi:10.1177/108705710000500204 · Cited by 208
Homogeneous fluorescence readouts for miniaturized high-throughput screening: theory and practice
Pope, A. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01340-9 · Cited by 199
Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases
Sharon, N., & Ofek, I. (2000) · Glycoconjugate Journal · doi:10.1023/a:1011091029973 · Cited by 193
Fluorescence Polarization (FP) Assays for Monitoring Peptide‐Protein or Nucleic Acid‐Protein Binding
Moerke, N. J. (2009) · Current Protocols in Chemical Biology · doi:10.1002/9780470559277.ch090102 · Cited by 191
Swillens, S. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08761-9 · Cited by 187
Huang, X. (2003) · SLAS Discovery · doi:10.1177/1087057102239666 · Cited by 183
Trosset, J., Dalvit, C., Knapp, S., Fasolini, M., Veronesi, M., Mantegani, S., Gianellini, L. M., Catana, C., Sundström, M., Stouten, P. F. W., et al. (2006) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20955 · Cited by 181
Westphal, K. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.107579 · Cited by 177
Protein–protein interactions and cancer: small molecules going in for the kill
Arkin, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.03.001 · Cited by 175
The Year In G Protein-Coupled Receptor Research
Millar, R. P., & Newton, C. L. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0473 · Cited by 167
[12] Fluorescence anisotropy applied to biomolecular interactions
Jameson, D. M., & Sawyer, W. H. (1995) · Methods in Enzymology · doi:10.1016/0076-6879(95)46014-4 · Cited by 164
Cy3B™: Improving the Performance of Cyanine Dyes
Cooper, M. E., Ebner, A., Briggs, M., Burrows, M., Gardner, N., Richardson, R., & West, R. (2004) · Journal of Fluorescence · doi:10.1023/b:jofl.0000016286.62641.59 · Cited by 153
Stains, labels and detection strategies for nucleic acids assays
Kricka, L. J. (2002) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/0004563021901865 · Cited by 141
Aptamers as tools for target validation
Blank, M., & Blind, M. (2005) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2005.06.011 · Cited by 128
Fluorescence readouts in HTS: no gain without pain?
Gribbon, P. M., & Sewing, A. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02895-2 · Cited by 128
Fluorescence Polarization: An Analytical Tool for Immunoassay and_ Drug Discovery
Nasir, M. S., & Jolley, M. E. (1999) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/1386207302666220204192916 · Cited by 124
Development and Application of Fluorescence Polarization Assays in Drug Discovery
Burke, T. J., Loniello, K., Beebe, J., & Ervin, K. M. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298365 · Cited by 120
A coupled fluorescent assay for histone methyltransferases
Collazo, E., Couture, J., Bulfer, S. L., & Trievel, R. C. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.007 · Cited by 117
A Novel Class of Small Molecule Inhibitors of Hsp90
Yi, F., & Regan, L. (2008) · ACS Chemical Biology · doi:10.1021/cb800162x · Cited by 116
Extending the Applicability of Carboxyfluorescein in Solid-Phase Synthesis
Fischer, R., Mader, O., Jung, G., & Brock, R. E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025658b · Cited by 115
Fluorescence Polarization: Past, Present and Future
Jameson, D., & Croney, J. C. (2003) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620703106298347 · Cited by 114
An Exact Correction to the “Cheng-Prusoff” Correction
Munson, P. J., & Rodbard, D. (1988) · Journal of Receptor Research · doi:10.3109/10799898809049010 · Cited by 110
Allen, M. J., Reeves, J. J., & Mellor, G. W. (2000) · SLAS DISCOVERY · doi:10.1177/108705710000500202 · Cited by 103
Turek-Etienne, T. C., Small, E. C., Soh, S. C., Xin, T. A., Gaitonde, P. V., Barrabee, E. B., Hart, R. F., & Bryant, R. W. (2003) · SLAS DISCOVERY · doi:10.1177/1087057103252304 · Cited by 102
[1] Equilibrium and kinetic inhibition assays based upon fluorescence polarization
Dandliker, W. B., Hsu, M.-L., Levin, J., & Rao, B. R. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(81)74003-5 · Cited by 88
Current In Vitro Kinase Assay Technologies: The Quest for a Universal Format
Jia, Y., Quinn, C. T., Kwak, S., & Talanian, R. V. (2008) · Current Drug Discovery Technologies · doi:10.2174/157016308783769414 · Cited by 85
A Homogeneous, Fluorescence Polarization Assay for Src-Family Tyrosine Kinases
Seethala, R., & Menzel, R. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2365 · Cited by 73
Vaasa, A., Viil, I., Enkvist, E., Viht, K., Raidaru, G., Lavõgina, D., & Uri, A. (2008) · Analytical Biochemistry · doi:10.1016/j.ab.2008.10.030 · Cited by 61
Measurement of Specific Protease Activity Utilizing Fluorescence Polarization
Levine, L. M., Michener, M. L., Toth, M. V., & Holwerda, B. C. (1997) · Analytical Biochemistry · doi:10.1006/abio.1997.2047 · Cited by 59
Characterization and Optimization of a Red-Shifted Fluorescence Polarization ADP Detection Assay
Kleman-Leyer, K. M., Klink, T. A., Kopp, A. L., Westermeyer, T. A., Koeff, M. D., Larson, B., Worzella, T. J., Pinchard, C. A., van de Kar, S. A. T., Zaman, G. J. R., et al. (2009) · Assay and Drug Development Technologies · doi:10.1089/adt.2008.175 · Cited by 57
Fluorescence Polarization: Analysis of Carbohydrate–Protein Interaction
Kakehi, K., Oda, Y., & Kinoshita, M. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5309 · Cited by 56
A chemiluminescence-based method for identification of histone lysine methyltransferase inhibitors
Quinn, A. M., Allali‐Hassani, A., Vedadi, M., & Simeonov, A. M. (2010) · Molecular BioSystems · doi:10.1039/b921912a · Cited by 54
Self-citationKecskés, M., Kumar, T. S., Yoo, L. S., Gao, Z., & Jacobson, K. A. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.04.027 · Cited by 49
Wigle, T. J., Provencher, L. M., Norris, J. L., Jin, J. J., Brown, P. J., Frye, S. V., & Janzen, W. P. (2010) · Chemistry & Biology · doi:10.1016/j.chembiol.2010.04.014 · Cited by 49
Simeonov, A. M., Yasgar, A., Jadhav, A., Lokesh, G. L.-R., Klumpp-Thomas, C. A., Michael, S., Austin, C. P., Natarajan, A., & Inglese, J. (2007) · Analytical Biochemistry · doi:10.1016/j.ab.2007.11.039 · Cited by 47
Self-citationTranscreener™: screening enzymes involved in covalent regulation
Lowery, R. G., & Kleman-Leyer, K. M. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.1.179 · Cited by 44
Duckworth, B. P., & Aldrich, C. C. (2010) · Analytical Biochemistry · doi:10.1016/j.ab.2010.04.009 · Cited by 40
Protein-Protein Interactions: Lessons Learned
Sharma, S., Ramsey, T. M., & Bair, K. W. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354191 · Cited by 38
A strategy to discover inhibitors of Bacillus subtilis surfactin-type phosphopantetheinyltransferase
Yasgar, A., Foley, T. L., Jadhav, A., Inglese, J., Burkart, M. D., & Simeonov, A. M. (2009) · Molecular BioSystems · doi:10.1039/b913291k · Cited by 36
Self-citationHuss, K. L., Blonigen, P. E., & Campbell, R. M. (2007) · SLAS DISCOVERY · doi:10.1177/1087057107300221 · Cited by 36
A non-radioactive method for the assay of many serine/threonine-specific protein kinases
Ross, H., Armstrong, C. G., & Cohen, P. (2002) · Biochemical Journal · doi:10.1042/bj20020786 · Cited by 35
Evaluating PI3 Kinase Isoforms Using Transcreener™ ADP Assays
Klink, T. A., Kleman-Leyer, K. M., Kopp, A. L., Westermeyer, T. A., & Lowery, R. G. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108319864 · Cited by 32
Zielinski, T. K., Kimple, A. J., Hutsell, S. Q., Koeff, M. D., Siderovski, D. P., & Lowery, R. G. (2009) · SLAS DISCOVERY · doi:10.1177/1087057109347473 · Cited by 32
Rowlands, M., McAndrew, C., Prodromou, C., Pearl, L. H., Kalusa, A., Jones, K., Workman, P., & Aherne, W. (2010) · SLAS DISCOVERY · doi:10.1177/1087057109360253 · Cited by 31
Development and Validation of a Transcreener Assay for Detection of AMP- and GMP-Producing Enzymes
Staeben, M., Kleman-Leyer, K. M., Kopp, A. L., Westermeyer, T. A., & Lowery, R. G. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2009.0254 · Cited by 30
Avidin plate assay system for enzymatic characterization of a histone lysine methyltransferase
Gowher, H., Zhang, X., Cheng, X., & Jeltsch, A. (2005) · Analytical Biochemistry · doi:10.1016/j.ab.2005.04.028 · Cited by 30
Kimple, A. J., Yasgar, A., Hughes, M., Jadhav, A., Willard, F. S., Muller, R. E., Austin, C. P., Inglese, J., Ibeanu, G. C., Siderovski, D. P., et al. (2008) · Combinatorial Chemistry & High Throughput Screening · doi:10.2174/138620708784534770 · Cited by 30
Self-citationKinase Assay Based on Thiophosphorylation and Biotinylation
Jeong, S., & Nikiforov, T. T. (1999) · BioTechniques · doi:10.2144/99276rr01 · Cited by 23
Assay Strategies for the Discovery and Validation of Therapeutics Targeting Brugia pahangi Hsp90
Taldone, T., Gillan, V., Sun, W., Rodina, A., Patel, P. D., Maitland, K., O’Neill, K., Chiosis, G., & Devaney, E. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000714 · Cited by 16
Cited by
Insights into Protein–Ligand Interactions: Mechanisms, Models, and Methods
Du, X., Li, Y., Xia, Y.-L., Ai, S.-M., Liang, J., Sang, P., Ji, X.-L., & Liu, S.-Q. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020144 · Cited by 1,657
Occurrence, Toxicity, and Analysis of Major Mycotoxins in Food
Alshannaq, A., & Yu, J.-H. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14060632 · Cited by 1,265
Seidel, S. A. I., Dijkman, P. M., Lea, W. A., van den Bogaart, G., Jerabek-Willemsen, M., Lazic, A., Joseph, J. S., Srinivasan, P., Baaske, P., Simeonov, A., et al. (2013) · Methods · doi:10.1016/j.ymeth.2012.12.005 · Cited by 642
Self-citationA practical guide to large-scale docking
Bender, B. J., Gahbauer, S., Luttens, A., Lyu, J., Webb, C. M., Stein, R. M., Fink, E. A., Balius, T. E., Carlsson, J., Irwin, J. J., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00597-z · Cited by 546
High-Throughput Screening: today’s biochemical and cell-based approaches
Blay, V., Tolani, B., Ho, S. P., & Arkin, M. R. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.07.024 · Cited by 387
Metadata
- Authors
- Lea, W. A., & Simeonov, A.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2010-11-19
- Volume
- 6
- Issue
- 1
- Pages
- 17-32
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2130437495
- Cited by
- 379
- References
- 75
- FWCI
- 3.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.